Recursion
Recursion is a TechBio company focused on reimagining drug discovery using AI, automation, and scientific expertise. They are developing a platform that integrates complex chemical data and scientific workflows to accelerate the design of new drug candidates, enhancing discovery programs and scientific impact.
Headquarters
Salt Lake City, Utah, United States
Company Size
501-1000 employees
Founded
2013
Recursion is a TechBio company that combines high-throughput experimental biology, automated imaging, and machine learning to decode biology and accelerate drug discovery. Its platform integrates large-scale biological datasets, AI models, and laboratory automation to identify and advance therapeutic candidates across multiple modalities and disease areas. Recursion develops an internal pipeline of programs and partners with biopharma and investors to translate discoveries into clinical-stage medicines. The company emphasizes a platform-first, scalable approach to make drug discovery faster, more reproducible, and more data-driven.
A Look At Recursion Pharmaceuticals (RXRX) Valuation After Q4 Beat And AI Clinical Progress
9 hours ago
Recursion Pharmaceuticals (NASDAQ:RXRX) CEO Sells $94,798.30 in Stock
17 hours ago
Recursion’s First AI Clinical Proof Links Pipeline Progress With Valuation Gap
2 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Recursion.
PacBio appoints Recursion co-founder Gibson to board
2 days ago
Scientific Director, Computational Chemistry
Neurocrine Biosciences
Principal Machine Learning Scientist, Drug Discovery Analytics
Revolution Medicines
Principal Scientist - Cheminformatics
GSK plc
Digital Product Owner, Research Decision Intelligence - Vaccines
Sanofi
Director, Computer-Directed Drug Design and AI-Native Molecular Design
Johnson & Johnson Medical Korea Limited
Computational Chemist
Magnet Biomedicine